Application of VascuLens 2.0, A Mixed Reality System for Surgical Guidance During DIEP Flap Harvest: A Randomized Controlled Trial
Launched by UNIVERSITY OF BRITISH COLUMBIA · Jul 14, 2025
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background and Rationale:
Breast reconstruction surgery is a surgical procedure that can be done after a breast removal surgery ("mastectomy"). One of the more common surgical methods for reconstruction involves taking a section of tissue from the abdomen that includes skin, fat, and blood vessels and relocating it to form the breast mound. This specific surgical method uses a section of the abdomen called the Deep Inferior Epigastric Artery Perforator (DIEP) flap. In order to accurately identify the necessary blood vessels for this surgery, surgeons generally take CTA (computed tomography...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients must be ≥ 19 years old
- • Patients must be undergoing a DIEP flap surgery after mastectomy for breast cancer or risk reduction
- • Patient is already scheduled for a pre-operative CTA as part of routine standard of care.
- • Note: Non-English speaking participants will be given the option to have a translator.
- Exclusion Criteria:
- • Patients who have had a prior DIEP flap, as they may not have standard vascular anatomy and the previous surgery may have resulted in scarring and fibrosis that would potentially interfere with the accuracy of the projected anatomical information.
- • Patients who have not had a pre-operative CTA because no imaging-based surgical guidance can be provided
- • Patients who are pregnant at the time of surgery
- • Patients who had a pre-operative CTA done before they were considered for this trial
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported